Therefore, ACE inhibitors have been widely prescribed for patients with both diabetic and non-diabetic symptoms to prevent angiotensin II production during the treatment of hypertension related to metabolic syndrome [27]. This evidence concerns the gene ACE and hypertensive disorder.